Sheba - English / Research / Research centers / The Joseph Sagol Neuroscience Center / Our Research / study protocol to investigate the added value of novel technologies for early detection of subtle symptoms and early pathology of Alzheimer’s disease
study protocol to investigate the added value of novel technologies for early detection of subtle symptoms and early pathology of Alzheimer’s disease
Description: This study will provide basic proof of concept of three potentially complementary novel neurotechnologies (BioEye, MyndYou, and Retispec) for the very early diagnosis and monitoring of AD.
Contact Person: Ben moshe Ariela Ariela.BenMoshe@sheba.health.gov.il
PI: Prof. Michal Schnaider-Beeri and Dr. Eithamar Ganmor
